Asia Pacific autoimmune disease diagnostics market will grow by 9.7% annually with a total addressable market cap of $19.06 billion over 2022-2031 owing to the growing prevalence of autoimmune diseases, the strong investment in research and development activities, the rise in technological advancements, increasing patient awareness and healthcare expenditure, and favorable government policies.
Highlighted with 35 tables and 70 figures, this 131-page report 鈥淎sia Pacific Autoimmune Disease Diagnostics 麻豆原创 2021-2031 by Product (Assay Kits & Consumables, Analyzers & Instruments), Test Type (Autoantibodies and Immunologic, Inflammatory Marker, Routine Laboratory, Others), Disease Type (Systemic, Localized), Gender (Female, Male), Age (<44, 44-64, >64), End User (Hospitals, Clinics, Diagnostic Labs), and Country: Trend Forecast and Growth Opportunity鈥� is based on a comprehensive research of the entire Asia Pacific autoimmune disease diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
鈥� 麻豆原创 Structure
鈥� Growth Drivers
鈥� Restraints and Challenges
鈥� Emerging Product Trends & 麻豆原创 Opportunities
鈥� Porter鈥檚 Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific autoimmune disease diagnostics market in every aspect of the classification from perspectives of Product, Test Type, Disease Type, Gender, Age, End User, and Country.
Based on Product, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Assay Kits & Consumables
鈥� Analyzers & Instruments
Based on Test Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Autoantibodies and Immunologic Tests
o Antinuclear Antibody Tests
o Anti-cyclic Citrullinated Peptide
o Enzyme-Linked Immunosorbent Assay (ELISA)
o Rheumatoid Factor
o Thyroid Antibody Tests
o Other Autoantibodies and Immunologic Tests
鈥� Inflammatory Marker Tests
o C-Reactive Protein (CRP)
o Erythrocyte Sedimentation Rate (ESR)
o Other Inflammatory Marker Tests
鈥� Routine Laboratory Tests
o Urinalysis
o Complete Blood Count (CBC) Tests
o Other Routine Laboratory Tests
鈥� Other Test Types
Based on Disease Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Systemic Autoimmune Disease
o Rheumatoid Arthritis
o Systemic Lupus Erythematosus (SLE)
o Psoriasis/Psoriatic Arthritis
o Other Systemic Autoimmune Diseases
鈥� Localized Autoimmune Disease
o Thyroiditis
o Multiple Sclerosis
o Inflammatory Bowel Disease
o Type 1 Diabetes
o Other Localized Autoimmune Diseases
Based on Gender, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Female Patients
鈥� Male Patients
Based on Age, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� < 44
鈥� 44 - 64
鈥� > 64
Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Hospitals
鈥� Clinics
鈥� Diagnostic Labs
鈥� Other End Users
Geographically, the following national/local markets are fully investigated:
鈥� Japan
鈥� China
鈥� South Korea
鈥� Australia
鈥� India
鈥� Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of the regional market by country and split of key national markets by Product, Disease Type, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott Laboratories
Beckman Coulter, Inc.
Biomerieux SA
Bio-rad Laboratories Inc.
F. Hoffmann-la Roche Ltd.
Hemagen Diagnostics Inc.
Myriad Genetics Inc.
PerkinElmer Inc. (Euroimmun AG)
Quest Diagnostics Inc.
Siemens Healthineers Inc.
Thermo Fisher Scientific Inc.
Trinity Biotech PLC
Werfen Company (Inova Diagnostics Inc.)
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 8
1.1 Industry Definition and Research Scope 8
1.1.1 Industry Definition 8
1.1.2 Research Scope 9
1.2 Research Methodology 12
1.2.1 Overview of 麻豆原创 Research Methodology 12
1.2.2 麻豆原创 Assumption 13
1.2.3 Secondary Data 13
1.2.4 Primary Data 13
1.2.5 Data Filtration and Model Design 14
1.2.6 麻豆原创 Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 麻豆原创 Overview and Dynamics 20
2.1 麻豆原创 Size and Forecast 20
2.1.1 Impact of COVID-19 on World Economy 21
2.1.2 Impact of COVID-19 on the 麻豆原创 23
2.2 Major Growth Drivers 25
2.3 麻豆原创 Restraints and Challenges 30
2.4 Emerging Opportunities and 麻豆原创 Trends 33
2.5 Porter鈥檚 Fiver Forces Analysis 37
3 Segmentation of Asia Pacific 麻豆原创 by Product 42
3.1 麻豆原创 Overview by Product 42
3.2 Assay Kits & Consumables 44
3.3 Analyzers & Instruments 45
4 Segmentation of Asia Pacific 麻豆原创 by Test Type 46
4.1 麻豆原创 Overview by Test Type 46
4.2 Autoantibodies and Immunologic Tests 48
4.2.1 Antinuclear Antibody Tests 50
4.2.2 Anti-cyclic Citrullinated Peptide 51
4.2.3 Enzyme-Linked Immunosorbent Assay (ELISA) 52
4.2.4 Rheumatoid Factor 53
4.2.5 Thyroid Antibody Tests 54
4.2.6 Other Autoantibodies and Immunologic Tests 55
4.3 Inflammatory Marker Tests 56
4.3.1 C-Reactive Protein (CRP) 58
4.3.2 Erythrocyte Sedimentation Rate (ESR) 59
4.3.3 Other Inflammatory Marker Tests 60
4.4 Routine Laboratory Tests 61
4.4.1 Urinalysis 63
4.4.2 Complete Blood Count (CBC) Tests 64
4.4.3 Other Routine Laboratory Tests 65
4.5 Other Test Types 66
5 Segmentation of Asia Pacific 麻豆原创 by Disease Type 67
5.1 麻豆原创 Overview by Disease Type 67
5.2 Systemic Autoimmune Disease 69
5.2.1 Rheumatoid Arthritis 71
5.2.2 Systemic Lupus Erythematosus (SLE) 72
5.2.3 Psoriasis/Psoriatic Arthritis 73
5.2.4 Other Systemic Autoimmune Diseases 74
5.3 Localized Autoimmune Disease 75
5.3.1 Thyroiditis 77
5.3.2 Multiple Sclerosis 78
5.3.3 Inflammatory Bowel Disease 79
5.3.4 Type 1 Diabetes 80
5.3.5 Other Localized Autoimmune Diseases 81
6 Segmentation of Asia Pacific 麻豆原创 by Gender 82
6.1 麻豆原创 Overview by Gender 82
6.2 Female Patients 84
6.3 Male Patients 85
7 Segmentation of Asia Pacific 麻豆原创 by Age 86
7.1 麻豆原创 Overview by Age 86
7.2 < 44 88
7.3 44 - 64 89
7.4 > 64 90
8 Segmentation of Asia Pacific 麻豆原创 by End User 91
8.1 麻豆原创 Overview by End User 91
8.2 Hospitals 93
8.3 Clinics 94
8.4 Diagnostic Labs 95
8.5 Other End Users 96
9 Asia-Pacific 麻豆原创 2021-2031 by Country 97
9.1 Overview of Asia-Pacific 麻豆原创 97
9.2 Japan 100
9.3 China 103
9.4 Australia 105
9.5 India 107
9.6 South Korea 109
9.7 Rest of APAC Region 111
10 Competitive Landscape 113
10.1 Overview of Key Vendors 113
10.2 New Product Launch, Partnership, Investment, and M&A 116
10.3 Company Profiles 117
Abbott Laboratories 117
Beckman Coulter, Inc. 119
Biomerieux SA 120
Bio-rad Laboratories Inc. 121
F. Hoffmann-la Roche Ltd. 122
Hemagen Diagnostics Inc. 123
Myriad Genetics Inc. 124
PerkinElmer Inc. (Euroimmun AG) 125
Quest Diagnostics Inc. 126
Siemens Healthineers Inc. 127
Thermo Fisher Scientific Inc. 128
Trinity Biotech PLC 129
Werfen Company (Inova Diagnostics Inc.) 130
RELATED REPORTS 131
Selected Key Players:
Abbott Laboratories
Beckman Coulter, Inc.
Biomerieux SA
Bio-rad Laboratories Inc.
F. Hoffmann-la Roche Ltd.
Hemagen Diagnostics Inc.
Myriad Genetics Inc.
PerkinElmer Inc. (Euroimmun AG)
Quest Diagnostics Inc.
Siemens Healthineers Inc.
Thermo Fisher Scientific Inc.
Trinity Biotech PLC
Werfen Company (Inova Diagnostics Inc.)
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
听
听
*If Applicable.
